These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 33396619)

  • 1. Application of microRNA Database Mining in Biomarker Discovery and Identification of Therapeutic Targets for Complex Disease.
    Major JL; Bagchi RA; Pires da Silva J
    Methods Protoc; 2020 Dec; 4(1):. PubMed ID: 33396619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA target prediction in glaucoma.
    Romano GL; Platania CB; Forte S; Salomone S; Drago F; Bucolo C
    Prog Brain Res; 2015; 220():217-40. PubMed ID: 26497793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantum Language of MicroRNA: Application for New Cancer Therapeutic Targets.
    Fujii YR
    Methods Mol Biol; 2018; 1733():145-157. PubMed ID: 29435930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening and identification of potential novel biomarker for diagnosis of complicated Plasmodium vivax malaria.
    Kaur H; Sehgal R; Kumar A; Sehgal A; Bansal D; Sultan AA
    J Transl Med; 2018 Oct; 16(1):272. PubMed ID: 30286756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HMDD v4.0: a database for experimentally supported human microRNA-disease associations.
    Cui C; Zhong B; Fan R; Cui Q
    Nucleic Acids Res; 2024 Jan; 52(D1):D1327-D1332. PubMed ID: 37650649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HMDD v2.0: a database for experimentally supported human microRNA and disease associations.
    Li Y; Qiu C; Tu J; Geng B; Yang J; Jiang T; Cui Q
    Nucleic Acids Res; 2014 Jan; 42(Database issue):D1070-4. PubMed ID: 24194601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HMDD v3.0: a database for experimentally supported human microRNA-disease associations.
    Huang Z; Shi J; Gao Y; Cui C; Zhang S; Li J; Zhou Y; Cui Q
    Nucleic Acids Res; 2019 Jan; 47(D1):D1013-D1017. PubMed ID: 30364956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computational Analysis of miRNA and their Gene Targets Significantly Involved in Colorectal Cancer Progression.
    Kandhavelu J; Subramanian K; Khan A; Omar A; Ruff P; Penny C
    Microrna; 2019; 8(1):68-75. PubMed ID: 30073936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identifying co-regulating microRNA groups.
    An J; Choi KP; Wells CA; Chen YP
    J Bioinform Comput Biol; 2010 Feb; 8(1):99-115. PubMed ID: 20183876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrative miRNA analysis identifies hsa-miR-3154, hsa-miR-7-3, and hsa-miR-600 as potential prognostic biomarker for cervical cancer.
    Zeng Y; Wang KX; Xu H; Hong Y
    J Cell Biochem; 2018 Feb; 119(2):1558-1566. PubMed ID: 28771797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA expression data analysis to identify key miRNAs associated with Alzheimer's disease.
    Chen J; Qi Y; Liu CF; Lu JM; Shi J; Shi Y
    J Gene Med; 2018 Jun; 20(6):e3014. PubMed ID: 29543360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating microRNAs as Potential Biomarkers of Endothelial Dysfunction in Obese Children.
    Khalyfa A; Kheirandish-Gozal L; Bhattacharjee R; Khalyfa AA; Gozal D
    Chest; 2016 Mar; 149(3):786-800. PubMed ID: 26270249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prediction of regulating network of innate immune signaling molecule hsa-miR-181a in stroke development based on bioinformatics analysis].
    Lyu Y; Qian Y; Fu L
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Aug; 31(8):1042-7. PubMed ID: 26271976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miRNA signature identification of retinoblastoma and the correlations between differentially expressed miRNAs during retinoblastoma progression.
    Yang Y; Mei Q
    Mol Vis; 2015; 21():1307-17. PubMed ID: 26730174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating miRNA Expression Profiling and Target Prediction in Patients Receiving Dexmedetomidine.
    Yang X; Chen H; Chen Y; Birnbaum Y; Liang R; Ye Y; Qian J
    Cell Physiol Biochem; 2018; 50(2):552-568. PubMed ID: 30308506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hsa-microRNA-181a is a regulator of a number of cancer genes and a biomarker for endometrial carcinoma in patients: a bioinformatic and clinical study and the therapeutic implication.
    He S; Zeng S; Zhou ZW; He ZX; Zhou SF
    Drug Des Devel Ther; 2015; 9():1103-75. PubMed ID: 25733820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA profiling reveals dysregulated microRNAs and their target gene regulatory networks in cemento-ossifying fibroma.
    Pereira TDSF; Brito JAR; Guimarães ALS; Gomes CC; de Lacerda JCT; de Castro WH; Coimbra RS; Diniz MG; Gomez RS
    J Oral Pathol Med; 2018 Jan; 47(1):78-85. PubMed ID: 29032608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioinformatic analysis of peripheral blood miRNA of breast cancer patients in relation with anthracycline cardiotoxicity.
    Yadi W; Shurui C; Tong Z; Suxian C; Qing T; Dongning H
    BMC Cardiovasc Disord; 2020 Feb; 20(1):43. PubMed ID: 32013934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel miRNAs as potential biomarkers in stage II colon cancer: microarray analysis.
    Gungormez C; Gumushan Aktas H; Dilsiz N; Borazan E
    Mol Biol Rep; 2019 Aug; 46(4):4175-4183. PubMed ID: 31123908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrated analysis of microRNA regulation and its interaction with mechanisms of epigenetic regulation in the etiology of systemic lupus erythematosus.
    Navarro Quiroz E; Navarro Quiroz R; Pacheco Lugo L; Aroca Martínez G; Gómez Escorcia L; Gonzalez Torres H; Cadena Bonfanti A; Marmolejo MDC; Sanchez E; Villarreal Camacho JL; Lorenzi H; Torres A; Navarro KF; Navarro Rodriguez P; Villa JL; Fernández-Ponce C
    PLoS One; 2019; 14(6):e0218116. PubMed ID: 31237906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.